| Autor: |
Maestrini HA; Department of Glaucoma, Oculare Hospital de Oftalmologia, Belo Horizonte, MG, Brazil., Maestrini AA; Department of Glaucoma, Oculare Hospital de Oftalmologia, Belo Horizonte, MG, Brazil., Cenachi SPF; Department of Uveitis, Oculare Hospital de Oftalmologia, Belo Horizonte, MG, Brazil., Massote JA; Department of Glaucoma, Oculare Hospital de Oftalmologia, Belo Horizonte, MG, Brazil., Lopes AB; Department of Glaucoma, Oculare Hospital de Oftalmologia, Belo Horizonte, MG, Brazil., Fernandes TAP; Department of Glaucoma, Oculare Hospital de Oftalmologia, Belo Horizonte, MG, Brazil. |
| Jazyk: |
angličtina |
| Zdroj: |
Arquivos brasileiros de oftalmologia [Arq Bras Oftalmol] 2022 Sep 23. Date of Electronic Publication: 2022 Sep 23. |
| DOI: |
10.5935/0004-2749.2021-0239 |
| Abstrakt: |
We report a case of bilateral acute depigmentation of the iris in which satisfactory intraocular pressure control was obtained after resolution of the acute disease with a trabecular implant (iStent®). A 62-year-old woman presented with bilateral simultaneous acute eye pain, photophobia, increased intraocular pressure (34 mmHg), circulating pigment in the anterior chamber, areas of depigmentation in the iris, and posterior synechiae. She had received oral amoxicillin-clavulanate and moxifloxacin for pneumonia 2 months previously. Bilateral acute depigmentation of the iris was suspected as well as a viral etiology. She received oral acetazolamide, aciclovir, and prednisone, besides topical prednisolone, betaxolol, brimonidine, dorzolamide, and atropine. The disease gradually resolved in 4 months but, after 1 year, she developed bilateral cataracts, and still needed three drugs for intraocular pressure control (16/18 mmHg). Cataract-iStent® combined surgery was performed in both eyes. One year after surgery, intraocular pressure was 11/12 mmHg, without medication. iStent® was safe and effective on this secondary glaucoma. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
